CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP

Core Insights - CS Diagnostics Corp. (CSDX) is launching a multi-channel sales strategy for its MEDUSA SDP product, focusing on both institutional and consumer markets [1][2]. Sales Strategy - The company plans to utilize a diversified sales model that includes B2B and B2C distribution channels [2]. - B2B distribution channels will target hospitals, healthcare facilities, gyms, wellness centers, schools, corporate clients, and industrial clients [4]. - B2C channels will include physical retail stores in the UAE and Germany, online marketplaces like Amazon and Noon, and direct-to-consumer sales via the official MEDUSA e-commerce website [4]. Logistics and Sustainability - DHL has been selected for bulk and institutional shipments, while FedEx will handle retail and consumer deliveries [6]. - The company is also pursuing regulatory approval for a biodegradable, dissolving line of MEDUSA SDP wet wipes, which aligns with its sustainability roadmap [6]. Company Overview - CS Diagnostics Corp. is a medical technology company focused on infection control and oncology, with products including the MEDUSA platform and CS Protect-Hydrogel [8]. - The company is advancing through key commercialization milestones, including strategic manufacturing partnerships and multi-region launches across the GCC and Europe [8]. - Plans for future product introductions include biodegradable hygiene products and international expansion [8].